Diederick E. (Rick) Grobbee is Chief Scientific Officer at Julius Clinical, and a Professor of Clinical Epidemiology at the University Medical Center (UMC) Utrecht, the Netherlands. His other current roles include Chair of the focus area Circulatory Health at the UMCU.
Aize joined Julius Clinical in December 2015. He values true cooperation and a partnership approach with our client base as well as with academic partners and site networks to achieve real innovative results.
Arnoud joined Julius Clinical in June 2018. He believes that success is driven by focus, commitment, getting it done, organisational talent and an intrinsic motivation to increase people’s personal performance.
For over 25 years, Hans has been supporting the clinical development of novel therapies across various therapeutic areas, but in particular, cardiovascular and metabolic indications. His experience covers the full range of clinical development from first-in man until global phase III cardiovascular outcomes studies.
Eric joined us in September 2018. His responsibilities include the provisioning of state of the art solutions and efficient IT services to support our strategic business priorities and operations. He has a background in electronics and more than 20 years’ experience in IT (15 years in the CRO industry) spanning across engineering, consulting, management and has fulfilled multiple regional and global leadership roles.
Chief financial officer
Hans joined Julius Clinical in January this year (2019). He is responsible for taking on a leadership role in financial decision-making that affects Julius Clinical. Furthermore he is overseeing the overall accounting process and plays a key role in developing and implementing financial procedures that improve and maintain the financial health of Julius Clinical.